antiviral agents Flashcards
Why are viruses so hard to treat?
- Viral latency in recurrent episodic infection (ie HSV)
- Obligate intracellular location/syncytia formation
- Usurp host cellular mechanisms of replication (enzymes, ribosomes etc.)
- Display host external antigens
- Rapid mutation (HIV-1, hep C)
What are the three major categories of antiviral agents?
- Virucidal: directly inactivate intact viruses
- Immunomodulating: augment or modify host response to infection
- Antiviral: inhibit viral replication at cellular level
What are virucidal agents?
- Inactivate in single or multiple steps
- Physical disruption – crude
- Also kill infected cells
- Major agents: detergents, organic solvents, ultraviolet light, cautery, cryotherapy, podophyllin
- Important for environmental sterilization eg. Bleach for Hantavirus in mouse droppings or for HIV or HCV in spilled blood
What are immunomodulating agents?
Supplement deficient host immune response
a) Vaccination (prevention is always preferable): produces neutralizing antibodies
b) Passive immunotherapy – exogenous antibody is given to neutralize virus. Prophylaxis or early treatment (RIG, VZIG, HBIG, CMVIG, TIG, RSVIG). May work for Ebola. Renewed interest for HIV.
c) Stimulate Cell Mediated Immunity (CMI) locally: Imiquimod, Resiquimod: induce TNF, IFNα and induce macrophages to produce NO
d) Stimulate CMI systemically (or locally) – interferons
o IFN alpha (leukocytes) – pegylated IFN as well
o IFN beta (fibroblasts)
o IFN gamma (T-lymphs)
o Immunogenic proteins of 160-180 amino acids
o Multiple preparations from mixtures, “purified natural” to recombinant
o Mechanism – complex:
• Binds to cellular receptors to exert direct inhibitor effect on viral replication.
• Also immunomodulates through enhancement of macrophage activity and augmentation of cytotoxic lymphocyte actions.
What are the indications for immunomodulating agents?
o Indications:
• Non-infectious (Hairy cell leukemia, idiopathic thrombocytopenic purpura (ITP), Kaposi’s sarcoma (KS)
• Hepatitis B, chronic active
• Hepatitis C, chronic active and maybe acute. Unlikely to be used for HCV in the future due to availability of direct acting agents which are more effective and less toxic.
• Condylomata accuminata
• HIV
What is the toxicity and administration frequency and method for immunomodulating agents?
o Toxicity:
• Influenza-like symptoms (fever, myalgia, chills)
• Leukopenia
• Rare renal, hepatic toxicity
• Drowsiness to coma (rare)
• Autoimmune problems (diabetes, hypothyroidism)
• Depression
o Administered once daily or 3x/week IV, SC, IM
What is the spectrum and pharmacology for the specific antiviral agent Amantadine/Rimantadine?
Spectrum – influenza A (and Parkinson’s Disease)
Pharmacology - well absorbed
- Peak levels at 3 to 4 hours - Renal excretion - T ½ 12 hours: ↑ elderly and renal dysfunction
What is the toxicity and clinical uses for the specific antiviral agent Amantadine/Rimantadine?
Toxicity - GI (nausea, ↓appetite)
- CNS (nervousness, insomnia, difficulty concentrating)
Clinical uses - Prevention and treatment influenza A
- Prophylactic tx indicated for elderly (>65), chronically ill, hospital personnel, household contacts who are unvaccinated and at risk from time of outbreak – 6 weeks (2 weeks if vaccinated)
- Effective tx if started within 48 hours of symptoms
- Rimantadine = analogue of amantadine with less CNS side effects
- Resistance is rampant
What is the spectrum and pharmacology for the neuraminidase inhibitors, osteltamivir and Zanamivir?
Spectrum – influenza A and B
Pharmacology - Zanamivir has no oral absorption: aerosol
- Oseltamivir is well-absorbed
- No renal adjustment
What is the toxicity and clinical uses for the neuraminidase inhibitors, osteltamivir and Zanamivir?
Toxicity - Zanamavir: bronchospasm rarely
- Oseltamivir: GI (nausea, diarrhea) 10%
Clinical Uses - Prevention and treatment of influenza A and B
- Effective only if started with 36 hour of symptoms
- Use restricted by cost, minimal benefit
- Resistance is increasingly common
What is the spectrum and pharmacology for the capsid protein function inhibition?
Spectrum - Enteroviruses, Rhinoviruses
Pharmacology - Orally bioavailable
- Good blood/brain barrier penetration
- Compresses and makes rigid the viral capsid
What is the toxicity and clinical use for the capsid protein function inhibition?
Toxicity - Appears minimal
Clinical uses - Preliminary studies, not licenses
- Treatment and prevention of colds
- Treatment of enteroviral meningitis
What is the nucleotide/nucleoside analogue Idozuridine for?
- Iodinated thymidine analogue
- Inhibits viral DNA synthesis
- Mainly used for HSV keratitis
What is the nucleotide/nucleoside analogue trifluridine for?
- Fluorinated thymidine analogue
- Inhibits viral DNA synthesis
- Mainly used for HSV keratitis
- Greater activity than Idoxuridine
What is the nucleotide/nucleoside analogue acylovir (valacyclovir, famciclovir too) spectrum and action as well as resistance?
Spectrum - Active HSV-1, HSV-2, VZV, some EBV
- Twice as active HSV over VZV - ?Not against CMV Action - Inhibits viral DNA synthesis
Acyclovir Thymidine Acyclovir – monophosphate → ↓ Kinase ↓ host ↓ enzymes Acyclovir triphosphate Blocks viral DNA polymerase Chain terminator
Resistance - TK deficient viruses - Altered DNA polymerase